Stocks
Incyte CorporationINCY
NASDAQHealthcareBiotechnology$92.54+0.55%
A biotechnology company focused on developing and commercializing small‑molecule drugs, primarily in oncology and inflammatory diseases. Its flagship product, Jakafi, is a leading treatment for myelofibrosis and other blood disorders and generates the majority of revenue, while a broader pipeline ta...
Market Cap: $18.4B52W Range: $53.56 – $112.29
Congressional Interest in Incyte Corporation (INCY)
7 members of Congress have disclosed 21 trades in Incyte Corporation (INCY), a Healthcare company. The buy/sell breakdown shows 7 purchases versus 14 sales, indicating net selling pressure from lawmakers. All data is sourced from STOCK Act periodic transaction reports filed with Congress.
Total Disclosures
21
Unique Politicians
7
Buys
7
Sells
14
Who in Congress Is Trading INCY?
| Date | Politician | Type | Amount |
|---|---|---|---|
| 2026-01-29 | Rohit Khanna | sell | $1K – $15K |
| 2025-05-15 | Rob Bresnahan | sell | $1K – $15K |